Lawmakers have been questioning Novo Nordisk, the company behind popular weight loss drugs Ozempic and Wegovy. The Senate wants to know why these medications are priced so much higher in the U.S. compared to other countries. For example, Americans with diabetes pay $969 per month for Ozempic, while
Imagine a world where drugs cost differently based on where you live. That's what happened at a recent Senate hearing in Washington, D.C. Novo Nordisk's CEO, Lars Fruergaard Jorgensen, was asked some tough questions about the high prices of two important medications: Ozempic for diabetes and Wegovy
The abortion issue continues to be a sticking point for many Republican candidates, particularly in key Senate races. Despite the party's confidence in taking control of the Senate, some Republicans are warning that comments like those made by Ohio GOP Senate hopeful Bernie Moreno, which seemed to d
As the 2024 presidential election approaches, Donald Trump's potential return to the White House raises questions about his ability to assemble a strong leadership team. Trump's record of high turnover and rocky relationships with his Cabinet members has left many wondering how he will fill his admi
The Right to In Vitro Fertilization (IVF) Act has been met with Republican resistance for the second time in four months, despite being championed by Senate Democrats. The debate has brought attention to the crucial issue of access to fertility treatments, highlighting the complexities and costs ass
The world of cryptocurrency has made a significant impact on the political scene, with crypto-backed super political action committees (PACs) making their first battleground Senate endorsements in the general election. These PACs, led by Fairshake, Defend American Jobs, and Protect Progress, have ra
The trauma inflicted on these gymnasts goes far beyond the physical abuse. It's about the emotional scars, the trust betrayed, and the sense of powerlessness that can linger long after the abuse has ended. It's about the silence that was forced upon them, and the courage it took to break that silenc
As Senator Sandra C. Cano stepped down from her position in the Rhode Island Senate, she left behind a legacy of impactful change. But what prompted her departure? Was it the allure of a new opportunity or a sense of fulfillment? The article hints at a potential job with the US Small Business Admini
As lawmakers in Washington turned their focus to the Steward Health Care bankruptcy scandal, it became clear that something was amiss. Despite a subpoena, CEO Ralph de la Torre refused to appear before the Senate Health, Education, Labor, and Pensions Committee, leaving an empty chair in his place.
The collapse of Steward Health Care's hospital system in Massachusetts is a stark reminder that even the most profitable businesses can succumb to mismanagement and greed. The impending Senate hearing on Thursday is a crucial moment to scrutinize the company's actions and the devastating impact on p
